BM

Bhat Muniyankula Venkateswaran Sambhu

Active Director Director DIN 00311247
DIN 00311247 First appointment Nov 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Nov 2006
Shareholding value •••• Premium profile

About Bhat Muniyankula Venkateswaran Sambhu

Data last updated:

Bhat Muniyankula Venkateswaran Sambhu is a Director at Systa Pharma Labs Private Limited (since 2009), Additional Director at Vintanova Pharma Private Limited (since 2012) and Director at Penta Labs Private Limited (since 2006). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹41.7 Lakh; the largest is Systa Pharma Labs Private Limited at ₹35.7 Lakh (FY 2021). Earlier, Bhat Muniyankula Venkateswaran Sambhu was a Director at Santa Pharma Generix Private Limited (from 2008) and Director at Aegen Bioteck Pharma Private Limited (from 2009) and 1 more.

DIN 00311247
Primary Designation Director
Industry Pharma
First Appointment 13 Nov 2006
Oldest Company Age 37 yrs
Largest company Systa Pharma Labs Private Limited · ₹35.7 Lakh (FY 2021)
Combined revenue ₹41.7 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Systa Pharma Labs Private Limited U24231KL1988PTC005263
Director15 Dec 20091988₹35.7 Lakh (FY 2021)Active
Vintanova Pharma Private Limited U24239KL2010PTC025656
Additional Director07 Mar 20122010₹6 Lakh (FY 2017)Active
Penta Labs Private Limited U24232KL2006PTC019998
Director13 Nov 20062006Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Santa Pharma Generix Private Limited U24233KL2008PTC023320
Director24 Oct 20082008₹3.4 Lakh (FY 2016)Strike Off
Aegen Bioteck Pharma Private Limited U24239KL2009PTC023773
Director30 Jan 20092009₹3.4 Lakh (FY 2016)Strike Off
Holdex Pharma Private Limited U24239KL2009PTC023774
Director30 Jan 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Bhat Muniyankula Venkateswaran Sambhu

Directorship timeline

Open interactive timeline →
Systa Pharma Labs Private Limited
Penta Labs Private Limited
Santa Pharma Generix Private Limited
Aegen Bioteck Pharma Private Limited
Premium access

Shareholding and investment profile for Bhat Muniyankula Venkateswaran Sambhu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhat Muniyankula Venkateswaran Sambhu

Bhat Muniyankula Venkateswaran Sambhu currently holds 3 directorships: Systa Pharma Labs Private Limited (Director, since 15 Dec 2009, revenue ₹35.7 Lakh (FY 2021)); Vintanova Pharma Private Limited (Additional Director, since 07 Mar 2012, revenue ₹6 Lakh (FY 2017)); Penta Labs Private Limited (Director, since 13 Nov 2006).

Bhat Muniyankula Venkateswaran Sambhu was first appointed on 13 Nov 2006 as Director at Penta Labs Private Limited. The most recent appointment on record is 07 Mar 2012 at Vintanova Pharma Private Limited.

The 2 current companies of Bhat Muniyankula Venkateswaran Sambhu that report revenue have a combined latest revenue of ₹41.7 Lakh: Systa Pharma Labs Private Limited ₹35.7 Lakh (FY 2021); Vintanova Pharma Private Limited ₹6 Lakh (FY 2017).

Bhat Muniyankula Venkateswaran Sambhu held 3 earlier board appointments: Santa Pharma Generix Private Limited (Director, from 24 Oct 2008); Aegen Bioteck Pharma Private Limited (Director, from 30 Jan 2009); Holdex Pharma Private Limited (Director, from 30 Jan 2009).

The current boards of Bhat Muniyankula Venkateswaran Sambhu's companies include Variketta Mallissery Sujatha Namboodiri (Systa Pharma Labs Private Limited), Vijayasree (Systa Pharma Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available